Skip to content

Faculty profile

Jacques Le Lorier

Back to faculty
ProfessorDépartement de pharmacologie et physiologieUniversité de Montréal

Latest papers

  • Cost-utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis.

    Current medical research and opinion · 2021

  • Assessing the risk of multiple sclerosis disease-modifying therapies.

    Expert review of neurotherapeutics · 2019

  • The burden of symptomatic skeletal events in castrate-resistant prostate cancer patients with bone metastases at three Canadian uro-oncology centres.

    Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2019

All 6 publications

Latest funding

  • Precision medicine study of type 2 diabetes in the COLCOT-T2D trial

    CIHR · 2021 · Co-investigator

    $1,800,000
  • Vascular events in patients undergoing same-day noncardiac surgery (VALIANCE) - a prospective cohort and nested biobank study

    CIHR · 2020 · Co-investigator

    $1,132,200
  • COLCOT-T2D : Colchicine for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes

    CIHR · 2020 · Co-investigator

    $5,446,800
All 11 grants and awards

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction